BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson BL, Abodeely A, Ferguson MA, Davis BR, Rafferty JF, Paquette IM. Is sacral neuromodulation here to stay? Clinical outcomes of a new treatment for fecal incontinence. J Gastrointest Surg. 2015;19:15-19; discussion 19-20. [PMID: 25115325 DOI: 10.1007/s11605-014-2611-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Dudding TC, Lehur PA, Sørensen M, Engelberg S, Bertapelle MP, Chartier-Kastler E, Everaert K, Van Kerrebroeck P, Knowles CH, Lundby L, Matzel KE, Muñoz-Duyos A, Rydningen MB, de Wachter S. Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice. Neuromodulation 2021. [PMID: 34264542 DOI: 10.1111/ner.13494] [Reference Citation Analysis]
2 Meurette G, Siproudhis L, Leroi AM, Damon H, Urs Josef Keller D, Faucheron JL; French Faecal Registry Study Group. Sacral neuromodulation with the InterStim™ system for faecal incontinence: results from a prospective French multicentre observational study. Colorectal Dis 2021;23:1463-73. [PMID: 33387373 DOI: 10.1111/codi.15507] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 De Meyere C, Nuytens F, Parmentier I, D’hondt M. Five-year single center experience of sacral neuromodulation for isolated fecal incontinence or fecal incontinence combined with low anterior resection syndrome. Tech Coloproctol 2020;24:947-58. [DOI: 10.1007/s10151-020-02245-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
4 Goldman HB, Lloyd JC, Noblett KL, Carey MP, Castaño Botero JC, Gajewski JB, Lehur PA, Hassouna MM, Matzel KE, Paquette IM, de Wachter S, Ehlert MJ, Chartier-Kastler E, Siegel SW. International Continence Society best practice statement for use of sacral neuromodulation. Neurourol Urodyn 2018;37:1823-48. [PMID: 29641846 DOI: 10.1002/nau.23515] [Cited by in Crossref: 55] [Cited by in F6Publishing: 34] [Article Influence: 18.3] [Reference Citation Analysis]
5 Rice TC, Quezada Y, Rafferty JF, Paquette IM. Dynamic Article: Percutaneous Nerve Evaluation Versus Staged Sacral Nerve Stimulation for Fecal Incontinence. Diseases of the Colon & Rectum 2016;59:962-7. [DOI: 10.1097/dcr.0000000000000668] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
6 Quezada Y, Whiteside JL, Rice T, Karram M, Rafferty JF, Paquette IM. Does preoperative anal physiology testing or ultrasonography predict clinical outcome with sacral neuromodulation for fecal incontinence? Int Urogynecol J. 2015;26:1613-1617. [PMID: 26017894 DOI: 10.1007/s00192-015-2746-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Bielefeldt K. Adverse events of sacral neuromodulation for fecal incontinence reported to the federal drug administration. World J Gastrointest Pharmacol Ther 2016; 7(2): 294-305 [PMID: 27158546 DOI: 10.4292/wjgpt.v7.i2.294] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]